The benefits of ASP in IBD have been attributed to the activation of Nrf2/HO-1 signaling, which induces antioxidant responses, and the suppression of the NFκB signaling pathway [22,181,182]. This evidence concerns the gene NFE2L2 and inflammatory bowel disease.